Want to join the conversation?
Cordis Corp., a part of $CAH, said that they have revealed a 4-year study data on "INCRAFT AAA Stent Graft System," which is used to treat patients with abdominal aortic aneurysms (AAA), is working well even after successfully completing 4 years of treatment with more than 97% freedom from endoleaks & no stent graft migrations.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.